- Current languageen
Pharmaceuticals - Community Register
Community register of veterinary medicinal products
|Invented name:||Hiprabovis IBR Marker Live|
|Auth. number :||EU/2/10/114|
|INN :||Live gE- tk- double-gene deleted Bovine Herpes Virus type 1 (BoHV-1), strain CEDDEL|
|ATC:||Anatomical main group: QI - Immunologicals|
Therapeutic subgroup: QI02 - Immunologicals for bovidae
Pharmacological subgroup: QI02A - Cattle
Chemical subgroup: QI02AD - Live viral vaccines
Chemical substance: QI02AD01 - Bovine rhinotracheitis virus (IBR)
(See WHO ATCvet Index)
|Indication:||For the active immunisation of cattle from 3 months of age against Bovine Herpes Virus type 1 (BoHV-1) to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.|
|Marketing Authorisation Holder:||Laboratorios Hipra, S.A.
Avda. La Selva, 135, E-17170- Amer (Girona), España
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".|
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.
|Close date procedure||Procedure type||EMEA number||Decision||summary publ||decision docs||annex|
|01/02/2011||Centralised - Authorisation||EMEA/V/C/158||(2011)579 of 27/01/2011|
|11/01/2012||Centralised - Variation||EMEA/V/C/158/II/1||(2012)90 of 09/01/2012|
|19/07/2013||Centralised - Variation||EMEA/V/C/15/IB/2|